PATENT CLAIM ANALYSIS

Application Number: 16354651
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["514", "005100"]

Abstract:
The invention relates to growth hormone compounds with a protracted profile. The effect is obtained by linking an albumin binding residue via a hydrophilic spacer to growth hormone variants. Further described are methods of preparing and using such compounds. These growth hormone compounds are based on there althered profile considered particular useful in therapy.

Claim (Index 11):
The conjugate of  claim 7 , wherein R 1 , R 2 , R 3 , R 4  and R 5  independently are selected from hydrogen, \u2014C(O)OH, \u2014C(O)NH 2 , \u2014S(O) 2 OH or C 1-6 -alkyl; wherein the alkyl group optionally is substituted with \u2014C(O)OH, \u2014C(O)NH 2  or \u2014S(O) 2 OH.

Metadata:
- Claim Count in Document: 36.0
- Percentile: 99.0
- Lexical Diversity: 1.31818
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13522390', '14132919', '13144757', '13574128', '12990101']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7756225159538751
- 35 USC 102 Novelty (BERT): 0.6597691143628921
- Combined Prediction Score: 0.7640371757947768
- Mean Citation Score: 456.2411679999999
- Max Citation Score: 676.3252
- Similarity Product: 590.366006693244

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test